Uncovering new frontiers in microbiology and EM

In this exclusive interview, industry experts Laure Pomares Voisin, Quality Director, Catalent Biologics and Tony Cundell Principal Consultant, Microbiological Consulting, share critical insights into the rapidly evolving landscape of pharmaceutical environmental monitoring and microbiology. They discuss the current challenges in rapid detection, adherence to newly revised EU Good Manufacturing Practice (GMP)Annex 1 guidelines, and the importance of robust personnel training. Furthermore, they delve into the future implications of rapid-test technologies and regulatory changes, while also shedding light on the latest innovations that promise to reshape sterility testing and contamination control.